{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-008129","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2024-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.746308+00:00","generated_at":"2026-06-06T15:56:34.969583+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Corbus reports preliminary cash of $20.9M as of Dec 31, 2023; raised $16.8M via ATM","bullets":["Raised approximately $16.8M in gross proceeds from common stock sales under Open Market Sale Agreement with Jefferies.","Preliminary cash, cash equivalents, and investments of ~$20.9M as of Dec 31, 2023, including $13.7M in cash.","Financial statements for year ended Dec 31, 2023 not yet finalized; amounts subject to adjustments.","Company has not provided any revenue or earnings guidance in this update."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-008129","json":"https://secwatch.observer/filing/0000950170-24-008129.json","markdown":"https://secwatch.observer/filing/0000950170-24-008129.md","text":"https://secwatch.observer/filing/0000950170-24-008129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024008129/0000950170-24-008129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024008129/crbp-20240129.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:56:34.969583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}